(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GSK

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

GSK

ST13

US500000079302538

Class

5, 9, 10

Filing

79302538

Registration

6465898

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

05/31/2025

Trademark type

Combined

Nice classes

5, 9, 10

Filing date

08/11/2020

Registration date

08/31/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/31/2021

Last transaction

05/31/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

98

Owner location

GB

Examiner

AGREDA, SAMANTHA

Law office

N50

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized letters "GSK" on a plectrum-like shape.

Holders and representatives

Holders

SmithKline Beecham Limited

Representatives

Christopher M. Hanes GSK

Technical classification

Nice Classes

Class 5Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Disinfectant sprays; pharmaceutical spraysantiviral coatings

Class 9

Protective face masks for the prevention of accident or injury; anti-pollution masks for respiratory protection

Class 10

Sanitary face masks for dental and medical purposes; surgical face masks; sanitary face masks for pollen isolation purposes; sanitary face masks for medical purposes for protection from viral transmission

Publications

History of USPTO decisions and trademark events.

42 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/30/2025

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

12/13/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/01/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/24/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/24/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/24/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/24/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/24/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/02/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

08/02/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/02/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/02/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/07/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/10/2022

FIMP

FINAL DISPOSITION PROCESSED

02/10/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/30/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

08/31/2021

ATRV

ATTORNEY REVIEW COMPLETED

07/26/2021

LIME

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

07/22/2021

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

06/19/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/15/2021

PUBO

PUBLISHED FOR OPPOSITION

06/15/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/26/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/11/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/19/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/19/2021

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

04/19/2021

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

03/08/2021

GNFR

FINAL REFUSAL E-MAILED

03/08/2021

CNFR

FINAL REFUSAL WRITTEN

03/08/2021

RFNT

REFUSAL PROCESSED BY IB

03/01/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/10/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/10/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/10/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/06/2021

RFRR

REFUSAL PROCESSED BY MPU

02/06/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/28/2021

CNRT

NON-FINAL ACTION WRITTEN

01/27/2021

MAFR

APPLICATION FILING RECEIPT MAILED

01/26/2021

DOCK

ASSIGNED TO EXAMINER

01/22/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/22/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/21/2021

Continuous trademark protection

Get notified about every new filing that threatens GSK or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.